Head-to-head comparison
BPC-157 vs TB-500
Physician-reviewed comparison
BPC-157
Emerging ResearchLegal to Compound
A synthetic pentadecapeptide showing promise in tissue repair and gut healing research.
TB-500
Emerging ResearchResearch Only
A synthetic fragment of thymosin beta-4 studied for tissue repair and anti-inflammatory effects.
Quick Comparison
| Dimension | BPC-157 | TB-500 |
|---|---|---|
| Category | peptide | peptide |
| Classification | Synthetic Pentadecapeptide (15 amino acids) | Synthetic Thymosin Beta-4 Fragment |
| Evidence Rating | Emerging Research | Emerging Research |
| Regulatory Status | Legal to Compound | Research Only |
| Delivery | Subcutaneous injection, Oral (capsule), Intramuscular injection | Subcutaneous injection, Intramuscular injection |
| Complexity | 4 / 5 | 4 / 5 |
| Refrigeration | Required | Required |
Dosing Comparison
BPC-157
Tissue Repair (Clinic Protocol)
200–500 mcg · daily
GI Healing (Oral)
250–500 mcg · daily
TB-500
Can You Stack Them?
Known interaction detected: minor
Commonly combined ("Wolverine stack") for tissue repair. Complementary mechanisms: BPC-157 (NO/angiogenesis) + TB-500 (cell migration/differentiation).
No known adverse interaction. Combined protocols widely used in clinic settings.
Medical Disclaimer
This comparison is for educational purposes only. Individual responses vary. Consult a qualified healthcare provider before using any compound.